To find out which Help At Hand program you may be eligible for, simply answer the
brief questionnaire below. Based on your answers, you’ll see if you may be eligible
for assistance through Takeda’s Patient Assistance Program (PAP), Together Rx Access® or the Partnership for Prescription Assistance (PPA).
Along with your results, you’ll find links to more information about the programs
you may qualify for and next steps for applying.
ACTOS, ACTOplus met, ACTOplus met XR, duetact, EDARBI and Rozerem are trademarks of Takeda Pharmaceutical Company Limited registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.
AMITIZA is a trademark of Sucampo Pharmaceuticals, Inc. registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.
DEXILANT is a trademark of Takeda Pharmaceuticals North America, Inc., registered in the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.
ULORIC is a trademark of Teijin Pharma Limited registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.
This program, as well as all Takeda Pharmaceuticals America, Inc. programs, can be discontinued or changed at any time without notice at the discretion of Takeda Pharmaceuticals America, Inc.